Condition: Smoking · Sponsor: Eli Lilly and Company
This study evaluates the efficacy and safety of brenipatide when compared to placebo for reducing the risk of relapse to cigarette smoking in adults who have recently quit. Study participation will last approximately 34 weeks with up to 17 study visits, which includes a 2-week screening period, 24-week treatment period, 8-week safety follow-up period.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Woodland Research Northwest | Rogers, Arkansas, United States | Recruiting |
| Hillcrest Medical Research | DeLand, Florida, United States | Active Not Recruiting |
| TecTum Research | Hollywood, Florida, United States | Recruiting |
| K2 Medical Research ORLANDO | Maitland, Florida, United States | Recruiting |
| GTL Medical & Research Group | Miami, Florida, United States | Recruiting |
| North Georgia Clinical Research | Woodstock, Georgia, United States | Recruiting |
| Revival Research Institute, LLC | Dearborn, Michigan, United States | Recruiting |
| Arch Clinical Trials | St Louis, Missouri, United States | Recruiting |
| Vector Clinical Trials | Las Vegas, Nevada, United States | Recruiting |
| Rochester Clinical Research, LLC | Rochester, New York, United States | Recruiting |
| Coastal Carolina Research Center | North Charleston, South Carolina, United States | Recruiting |
| Circle Clinical Research | Sioux Falls, South Dakota, United States | Recruiting |
+ 15 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07223840